T-bodies as antiviral agents.
Bitton
N
N
Laboratoire d'Immunologie Cellulaire, CERVI, INSERM U543, Hopital Pitie-Salpetriere, 83 Bvd de l'Hopital, 75013 Paris, France.
Debre
P
P
Eshhar
Z
Z
Gorochov
G
G
D000914:Antibodies, Viral / Q000276:immunology* / Q000627:therapeutic use; D000917:Antibody Formation; D000998:Antiviral Agents / Q000276:immunology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015316:Genetic Therapy / Q000379:methods; D015658:HIV Infections / Q000276:immunology / Q000628:therapy; D006564:Herpesviridae / Q000235:genetics / Q000276:immunology; D015368:Human T-lymphotropic virus 1 / Q000235:genetics / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D011995:Recombination, Genetic; D012680:Sensitivity and Specificity; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000914:Antibodies, Viral; D000998:Antiviral Agents; D011948:Receptors, Antigen, T-Cell